QQ客服 官方微博 反馈留言

	The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes
	Lu, Linghui; Wang, Shunni; Zhu, Qin; Qu, Yuqing; Gu, Weiyong; Ning, Yan; Chen, Xiaochen; Wang, Yiqin
刊名	PATHOLOGY RESEARCH AND PRACTICE
	2018
卷号	214期号:8
关键词	IMP3 Napsin-A HNF-1 beta Ovarian clear cell carcinoma Immunocytochemistry
ISSN号	0344-0338
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609486
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Lu, Linghui,Wang, Shunni,Zhu, Qin,et al. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes[J]. PATHOLOGY RESEARCH AND PRACTICE,2018,214(8).
APA	Lu, Linghui.,Wang, Shunni.,Zhu, Qin.,Qu, Yuqing.,Gu, Weiyong.,...&Wang, Yiqin.(2018).The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.PATHOLOGY RESEARCH AND PRACTICE,214(8).
MLA	Lu, Linghui,et al."The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes".PATHOLOGY RESEARCH AND PRACTICE 214.8(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。